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Background. We report a case of autoimmune retinopathy associated with anti-alpha-enolase antibodies with unique
manifestations. Methods.Ac a s er e p o r t .Results. A 30-year-old male experienced recurrent, primarily peripheral visual ﬁeld
disturbances and minimal photopsia, with interval symptom resolution. Fundus changes subsequently developed in areas
corresponding to the previous visual ﬁeld symptoms. Electroretinogram showed bilaterally symmetric abnormalities of light-
adapted responses and suggested loss of photoreceptor function. Only anti-alpha-enolase antibodies were detected on Western
blot. Our patient noted cutaneous symptoms at the time of both episodes of visual symptoms, but not in the interim.
Biomicroscopy revealed subtle small reddish spots in areas of the peripheral retina corresponding to the areas of the patient’s
visual ﬁeld where he noted symptoms. To our knowledge these reddish spots have not been reported in autoimmune retinopathy
and may clinically support in vitro and in vivo evidence that anti-alpha-enolase antibodies may target photoreceptors. Conclusions.
Our patient demonstrates some unique features adding to the known characteristics of autoimmune retinopathy associated with
anti-alpha-enolase antibodies. As more cases are reported, further understanding of the features and pathophysiology of this rare
condition will hopefully be elucidated.
1.Introduction
Autoimmune retinopathy (AIR) (nonparaneoplastic) and
cancer-associated retinopathy (CAR) (paraneoplastic) are
immunologically mediated retinal degenerations associated
with antibodies directed against retinal proteins. The lit-
erature varies in diagnostic criteria for AIR and ﬁrm
establishment of this diagnosis is challenging [1–3]. It has
been proposed that the presence of antirecoverin antibodies
(Ab) or anti-alpha-enolase Ab (AAEAb) is diagnostic of AIR
in the context of symptoms of acute or subacute vision loss,
abnormal electroretinogram (ERG), and exam ﬁndings of
diﬀuse retinal atrophy with little or no pigment deposition
[2, 3]. Photopsia, lack of cell or ﬂare, multiple bands of
antiretinal antibody activity on Western blot, electronegative
ERG, personal or family history of autoimmune disease, and
rapid progression are reportedly common in these patients
as well [2, 3]. Progression of AIR associated with AAEAb is
typicallyslowerthanprogressionofAIRassociatedwithanti-
recoverin Ab [1].
Approximately 30% of all patients with anti-retinal Ab
have AAEAb [4]. AAEAb are less predictive of associated
neoplasm than anti-recoverin Ab yet have been found in
patients who have skin cancer or cancers with endocrine
features [4]. CAR in patients with AAEAb typically develops
months to years after discovery of the malignancy [1].
While it has been suggested that AIR responds to cor-
ticosteroids or immunosuppression, the value of treatment
remains uncertain. Treatment is least eﬀective for nonpara-
neoplastic AIR [3]. One analysis found that corticosteroid
and immunosuppressive therapy were clinically ineﬀectivein
cases of AIR associated with AAEAb [1]. We report a case of2 Case Reports in Ophthalmological Medicine
AIR associated with AAEAb that has not required treatment
and exhibits unique manifestations.
2. Case Presentation
A 30-year-old Chinese male presented with episodic visual
disturbance. Symptoms began 18 months earlier with black
spots in the inferior visual ﬁeld (VF) OS. The spots were
more noticeable in dim lighting and moved centrally over 2
weeks. He denied ﬂashes, pain with eye movement, redness,
photophobia, nausea, vomiting, or headache. Throughout
the initial episode, visual acuity (VA) remained 20/20 in
each eye. Exam was remarkable only for mild retinal vessel
attenuation and perivascular pigment deposition in the
inferior periphery OS. Color vision, ﬂuorescein angiogram,
MRI brain/orbits, RPR, and FTA-Abs were normal. ERG
revealedbilaterallysymmetricabnormalitiesoflight-adapted
responses, including reduced 30-hertz ﬂicker amplitudes
with normal implicit times, and normal dark-adapted,
rod-mediated responses. The maximum scotopic rod-cone
response exhibited decreased a-wave amplitude suggesting
loss of photoreceptor function.
Theblackspotsgraduallyresolvedover4monthswithout
treatment. He remained asymptomatic, until returning one
year later noting sudden onset of dark spots in his inferotem-
poral VF OS and superior VF OD. He denied ﬂashes, pain,
photophobia, nausea, vomiting, and headache. Fluorescein
angiogram and Goldmann VF were within normal limits. He
was referred to our clinic 2 weeks later.
Bythen,hisblackspotshadbecomepinkish.Hereported
5 hours of intermittent ﬂashes 2 days prior, noticeable only
against a white background. VA remained 20/20 in each eye.
Fundus ﬁndings are shown. (Figures 1 and 2). All symptoms
had resolved without treatment 2 months following the
second episode’s onset.
Dermatologic ﬁndings that he described as itchy “hives”
or “welts” occurred with both episodes of visual symptoms.
During his ﬁrst episode, they recurred on his upper and
lower extremities then turned purple and resolved over
3 weeks. They did not recur once the visual symptoms
resolved. One week prior to the onset of his second episode,
they developed all over his body, with associated fever,
myalgias, abdominal ache, and fatigue. He denied nausea,
vomiting, diarrhea, or bloody stools. Symptoms resolved in
24 hours.Allergytesting wasnegative. Hedenied insect bites.
Home inspection for bedbugs was negative. A dermatologist
never examined him at these times.
A hypersensitivity to mosquito bites in Asians has
been reported in chronic active Epstein-Barr Virus (EBV)
infection [5]. Some suggest that AZOOR may be related to
Epstein-BarrVirus(EBV)[6].WetestedforEBVAb.IgMwas
negative. IgG was positive. These results, typical for much of
the population, suggest past infection with EBV. He had no
clinical signs of chronic active EBV infection.
A diagnosis of Acute Zonal Occult Outer Retinopathy
(AZOOR) was considered; however, a workup for AIR
was performed. Western blot testing for antibodies to
approximately 1200 retinal proteins revealed only AAEAb.
Figure 1: Color fundus photo montage OD. Exam was remarkable
for mild vessel narrowing with areas of hypopigmentation most
notable in the superotemporal periphery, although also noted in
the inferior/inferonasal periphery. Peripapillary depigmentation
(more evident temporally and less extensive than the ring of
depigmentation noted OS) is present. Biomicroscopy revealed
subtle reddish spots, not consistent with hemorrhage, within areas
corresponding to the areas of the visual ﬁeld where he described
symptoms. These subtle red spots were most notable in the far
inferonasal periphery and are diﬃcult to appreciate in the photos.
Figure 2: Color fundus photo montage OS. Vessel narrowing with
perivenular pigment deposition and surrounding hypopigmenta-
tion is noted in the superior periphery. On exam, perivascular
pigment deposition was also present in the far inferior periphery
(too peripheral to be captured in the photos). Hypopigmentation is
also noted in the inferior periphery. A ring of peripapillary depig-
mentation is evident. Subtle reddish spots (diﬃcult to appreciate
in the photos) were noted on biomicroscopy in the far inferior
periphery and far superonasal periphery.
Age-appropriate malignancy workup, including chest X-
ray, complete blood count with diﬀerential and platelets,
comprehensive metabolic panel, and physical by his primary
care physician were within normal limits. Dermatology
consult revealed no malignancies. There was no personal
or family history of autoimmune disease, including asthma,
thyroid disease, or inﬂammatory bowel disease. TestingCase Reports in Ophthalmological Medicine 3
for antinuclear Ab, p and c antinuclear cytoplasmic Ab,
myeloperoxidaseAb,proteinase3Ab,rheumatoidfactor,and
antiphospholipid Ab was negative. Erythrocyte sedimenta-
tion rate and C-reactive protein were within normal limits.
3. Discussion
AIR has been suggested to represent a secondary compli-
cation of other conditions, including AZOOR, with the
diagnosis of AIR established with detection of AAEAb in the
context of these symptoms [2]. Our patient shares features of
AIR and AZOOR, yet diﬀers from the typical presentations
of both.
RetinalpigmentchangescorrespondingtolocationofVF
symptoms, mild retinal vessel narrowing, sparing of central
vision, and reduced amplitude of 30-hertz ﬂicker responses
are consistent with AZOOR [7, 8]. Our patient developed
superior perivascular pigment deposition OS between the
ﬁrst and second episodes, presumably as a result of the
process causing the inferior VF symptoms during the ﬁrst
episode. Our patient’s diﬀerences from the typical AZOOR
presentation included scotomas more noticeable in dim
illumination, lack of prominent photopsias, symmetry of the
ERG between the 2 eyes, absence of delay in the 30-hertz
ﬂicker responses, and complete symptom resolution [7, 8].
Our patient’s symptoms were initially noted peripherally.
VA, Amsler grid, color vision, and Goldmann VF remained
normal. Onset was sudden. Typically, AIR associated with
AAEAb begins with evidence of central visual dysfunction
and onset is subacute or chronic [1]. Although gradual
progression is a hallmark of AIR, our patient has not
demonstratedprogressivevisionloss[2].Stepwisevisionloss
may occur in AZOOR [7].
One reported patient, who presented with scintillations,
good VA, and was initially diagnosed with AZOOR, was later
found to have AAEAb. Unlike our patient, that patient had a
normal fundus exam, asymmetric electroretinogram and VF
ﬁndings, and persistent VF defects [1].
Evidence suggests that AAEAb are intrinsically patho-
genic. AAEAb from patients with CAR have been shown
to induce apoptosis of retinal cells in vitro and in vivo,b y
targeting antigens in the ganglion cell and inner nuclear
layers, and also photoreceptors [1]. Biomicroscopy of our
patient disclosed subtle reddish spots within peripheral
retinal areas corresponding to the areas of his visual ﬁeld
where he described visual disturbances. In acute macular
neuroretinopathy (one of the AZOOR-complex diseases),
reddish lesions appear at the outer sensory retina, due to
outer retinal damage. Spectral domain optical coherence
tomography demonstrated photoreceptor outer segment
abnormalities that can explain blind spot enlargement in
AZOOR-complex diseases [9]. Perhaps the AAEAb in our
patient are damaging outer retinal cells, creating similar
reddish lesions, with subsequent photoreceptor loss.
In the context of his symptoms and clinical ﬁndings,
our patient can be diagnosed with AIR associated with
AAEAb. Anti-retinal antibody levels ﬂuctuate over time and
can serve as a biomarker for disease activity associated with
worsening of visual symptoms [10]. Perhaps the episodic
nature of our patient’s symptoms resulted from ﬂuctuating
AAEAb levels. Perhaps the skin reactions that our patient
had were triggers for or signs of increased immune system
activity, including increased levels of AAEAb and associated
symptomatic episodes. This single case demonstrates unique
ﬁndings and raises some interesting questions. As more cases
of AIR are accumulated and studied, hopefully a better
understanding of this rare condition will be achieved.
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